This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Ahern, J. A. Articles by Tamborlane, W. V. Search for Related Content PubMed PubMed Citation Articles by Ahern, J. A. Articles by Tamborlane, W. V. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Type 1 Social Bookmarking                         What's this?

Using a Primary Nurse Manager to Implement DCCT Recommendations in a Large Pediatric Program

Department of Pediatric Endocrinology, Yale University School of Medicine, PO Box 208064, New Haven, CT 06520-8064 JoAnn.Ahem{at}yale.edu

Neesha Ramchandani

Jake Cooper

Allison Himmel

David Silver, MEd

William V. Tamborlane, MD

Department of Pediatrics, the Children's Clinical Research Center, Yale University School of Medicine and Yale New Haven Hospital, New Haven, Connecticut.

PURPOSE

this study was conducted to determine whether recommendations from the Diabetes Control and Complications Trial (DCCT) could be implemented in a large pediatric population using a diabetes clinical nurse specialist program coordinator dedicated to intensive management.

METHODS

Patients' charts were reviewed to examine HbAic levels from before the results of the DCCT were published and again 1 year after the recommendations were implemented. Patients who met the following criteria (N=124) were enrolled: type 1 diabetes, less than 18 years old, followed at Yale for 1 year prior to the results of the DCCT and 1 year after, and HbA₁c level recorded in the medical chart.

RESULTS

HbA₁c levels were significantly lower 1 year after implementing the DCCT protocol; 3 years later these same patients improved even further as evidenced by another decrease in HbAlC levels. The patients were taking more insulin (more Ultralente and regular insulin and less NPH) and had an increased number of injections at both the 1-year and 3-year follow-up points.

CONCLUSIONS

The DCCT protocol can be implemented in a large population of pediatric patients with the help of a nurse who is dedicated and available to the patients for ongoing adjustments and provides creative ways to overcome the barriers to achieving normoglycemia.

The Diabetes Educator, Vol. 26, No. 6, 990-994 (2000)
DOI: 10.1177/014572170002600611


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				R. Whittemore, A. D. Urban, W. V. Tamboriane, and M. Grey Quality of Life in School-Aged Children With Type 1 Diabetes on Intensive Treatment and Their Parents The Diabetes Educator, September 1, 2003; 29(5): 847 - 854. [Abstract] [PDF]

				G. Spollett Case Study: A Patient With Uncontrolled Type 2 Diabetes and Complex Comorbidities Whose Diabetes Care Is Managed by an Advanced Practice Nurse Diabetes Spectr, January 1, 2003; 16(1): 32 - 36. [Full Text] [PDF]